UKMF

Future Meetings

• 09 Nov 2022 — Autumn Day 9 November 2022[ + ]

  The Autumn Day will take place on Wednesday 9 November 2022. This will be a hybrid meeting at the Cavendish Conference Centre in central London. The Chairs for this meeting are Dr Karthik Ramasamy and Dr Jonathan Sive.

  The theme for this meeting is, ‘Precursor states, gaps in data and resource in myeloma management’.

  Full Programme to follow.

   

Past Meetings

• 16 Mar 2022 — Spring Day 16 March 2022[ + ]

  The UKMF Spring Day took place on Wednesday 16th March 2022. This was a hybrid meeting at the Cavendish Conference Centre in central London, Chaired by Dr Rachel Hall and Dr Neil Rabin

  The theme for this meeting was ‘Relapsed Myeloma and the Impact of Covid-19’. Thank you to all our speakers, particularly the Michael Morley guest lecture, Dr Vincent Rajkumar from the Mayo Clinic in Rochester who presented on ‘ How I treat relapsed myeloma: a global perspective’.

  The next educational meeting will take place on Wednesday 9th November 2022 at the Cavendish Conference Centre. Details will follow.

  Presentations can be downloaded below.

  • Programme — Dr Neil Rabin & Dr Rachel Hall
  • Myeloma and COVID: Impacts now and in the future — Prof Gordon Cook
  • How I treat early relapse of myeloma — Dr Karthik Ramasamy
  • CAR-T Update — Prof Hermann Einsele
  • EFFICACY OF ISATUXIMAB WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED MYELOMA: RESULTS OF A UK-WIDE REAL-WORLD DATASET — Dr Faouzi Djebbari
  • Multistate models demonstrate that lenalidomide maintenance enhances survival by prolonging time in first remission for patients treated in the UK NCRI Myeloma XI randomised trial — Zoe Craig
  • TRIM33 Loss in Multiple Myeloma Impairs the DNA Damage Response Resulting in Sensitivity to PARP and ATR Inhibitors — Roisin McAvera
  • 820: Residual Monoclonal Free Light Chain Positivity By Mass Spectrometry Identifies Patients at Increased Risk of Early Relapse Following First-Line Anti-Myeloma Treatment — Hannah Giles
  • Daratumumab, Bortezomib and dexamethasone (DVd) at first relapse for patients with Relapsed/ Refractory Multiple Myeloma (RRMM): a UK Myeloma Research Alliance (UK-MRA) real-world multicentre analysis — Annabel McMillan
• 11 Nov 2021 — Autumn Day 2021[ + ]

  The UKMF Autumn Day took place on Thursday 11th November 2021.  Thank you to our generous sponsors.

  The theme for the meeting was the ‘Sequencing Therapy and Personalised Medicine in Myeloma’ and we are were delighted to welcome the Michael Morley guest speaker Prof Faith Davies from NYU Grossman School of Medicine who presented on ‘My current approach to sequencing therapy in myeloma and how this can be refined with personalised therapy’.

  We were also delighted to welcome the other international speakers,Dr Inger Nijhok, Dr Shaji Kumar and Prof Sagar Lional. Please see below for a full programme.

  Presentations from the day can be found below.

  Our next event will be the Spring Day on 16th March 2022. For more details, please visit our meeting page.

   

  • Autumn Day programme — Dr Ceri Bygrave and Dr Sarah Lawless
  • MY CURRENT APPROACH TO SEQUENCING THERAPY AND HOW THIS CAN BE REFINED WITH PERSONALIZED THERAPY — Prof Faith Davies
  • New UKMF/ BSH guidelines on 1st line treatment — Dr Jonathan Sive
  • Treatment of genetically high risk myeloma: latest update from the MUK 9 trial — Dr Matthew Jenner
  • Discrepancies in ethnic diversity of patients enrolled into UK multiple myeloma clinical trials — Dr Samir Asher
  • Front line treatment in Europe — Dr Inger Nijhof
  • Front line treatment worldwide/ US — Dr Shaji Kumar
  • How can we use trial data and real word experience to inform our approach to sequencing therapy? — Prof Sagar Lonial
  • Current controversies surrounding consolidation and maintenance followed autologous stem cell transplantation in NDTEMM — Prof Graham Jackson
  • Personalising the management of patients with MGUS and Smouldering Myeloma q — Dr Jenny Bird
  • Impact of Covid-19 on autologous stem cell transplantation (ASCT) in multiple myeloma patients: a single-centre, qualitative study — Dr Marquita Camilleri
• 17 Mar 2021 — Spring Day 2021[ + ]

  The UKMF Spring Day took place on Wednesday 17th March 2021.  Thank you to our generous sponsors.

  The theme for the meeting was the ‘Impact of Covid on MM management’ and we are were delighted to welcome the Michael Morley guest speaker Dr Maheshi Ramasamy from the University of Oxford who presented on ‘The Oxford Astra Zeneca vaccine – developing a global vaccine against COVID-19’.

  Presentations for the meeting can be dowloaded below

  • Spring Day 2021 Programme — Dr John Ashcroft and Prof Guy Pratt
  • Amyloidosis Update — Prof Ashutosh Wechalekar
  • The impact of COVID from a nursing perspective — Sarah Henshaw
  • UK Myeloma Trial update — Dr Rakesh Popat
  • Current management pathways for treatment of multiple myeloma — Prof Graham Jackson
  • Management of the Elderly and Frail Patient — Prof Gordon Cook
  • LLOGENEIC STEM CELL TRANSPLANTATION — Prof Mark Cook
  • Auto or not — Dr Neil Rabin
  • Treatment of a young patient with a poor response to first line therapy — Dr Ceri Bygrave
  • Panobinostat in combination with Bortezomib and Dexamethasone (PAN-Vd) for Heavily Pre-treated Myeloma: A UK Real-World Multi-centre Cohort — Nadjoua Maouche
  • The Impact of Longitudinal Strain on Haematological and Cardiac Response and Survival in Patients with Systemic AL Amyloidosis — Dr Oliver Cohen
  • Ocular Health of patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline data from DREAMM-2 trial of Belantamab Mafadotin — Aikaterini Kazantzi
• 11 Nov 2020 — Autumn Day 2020[ + ]

  The UKMF Autumn Day on 11th November 2020 was an all-virtual event, given the continuing threat of the COVID-19 pandemic. Please see below for talks that were presented on the day as well as the programme.

  We look forward to seeing you at the next educational meeting on 17th March 2020. This event will also be virtual. To register, please email www.collaborativeconferences.co.uk.

  Thank you

   

  • Autumn Day Programme — Dr Rakesh Popat, Dr Matthew Jenner
  • Novel trial designs — Dr Andrew Hall
  • Incorporating genetics into clinical trials — Dr Martin Kaiser
  • Use of MRD as an endpoint in trials — Dr Roger Owen
  • Bispecific T cell engagers — Prof Gordon Cook
  • Virus and vaccines — Dr Christoher Parrish
  • NK Cells — Prof Michael O'Dwyer
  • 10 lessons — Prof Kwee Yong
  • CAR-T cells — Reuben Benjamin
  • Reflections on a career in Myeloma care — Prof Steve Schey
  • Use of PET scans in Clinical Trials — Dr Simon Wan
• 19 Mar 2020 — Scientific Workshop 2020[ + ]

  Cancellation Notice

  Since our website communications of 6th March 2020, the situation of COVID-19 has been rapidly evolving. The number of infections has increased substantially in numerous countries worldwide, leading to further international restrictions regarding the hosting of events and congresses by governments and health authorities. The situation in the UK is changing on a daily basis, with a number of medical conferences including that of the Royal College of Physicians being postponed. A number of our sponsors, presenters and members are now unable to attend due to corporate/organisations decisions out with their control.

  The executive of the UKMF have therefore reluctantly made the decision to postpone the Scientific Workshop planned for the 19^th March at the Cavendish Conference Centre in London. The meeting is now provisionally planned to be held on 11^th November 2020 at the same venue, please do save the date.

  In order to minimize inconvenience we will arrange refunds for any registration payments already made. These will be organised through Collaborative Conferences. The conferences team should be contacting you directly over the coming days but if there are any questions please contact Alex@collaborativeconferences.co.uk.

  We would like to thank our members, speakers, the conference venue and suppliers for their cooperation and understanding during this time.  Despite this difficult situation, we do very much appreciate your support and are working hard to ensure the 11^th November meeting is a great success.

  On behalf of the UKMF Exec.

  • Scientific Workshop 2020 — Matthew Jenner & Rakesh Popat
• 07 Nov 2019 — Autumn Day 2019[ + ]

  The UKMF Autumn Day took place on Thursday 7th November 2019 at the Cavendish Conference Centre in central London.

  The theme was ‘The Management of Relapsed Disease and its Consequences’.

  Please see programme below. We had a well attended and successful meeting. We are sharing the presentations below.

  Look out for details on the Scientific Workshop programme in March 2020.

   

  • Autumn Day Programme — Dr S Stern & Dr R Soutar
  • Endpoints and treatment goals in relapsed/ refractory myeloma — Prof Xavier Leleu
  • Clinically available alternatives in the relapse setting — Dr Kevin Boyd
  • Valedictory Lecture — Prof TCM Morris
  • Where are we going with treatment costs in myeloma? — Prof Olivia Wu
  • How to manage increasing workload in the myeloma clinic — Ms Sarah Henshaw
  • Optimal management of relapsed disease — Dr Matthew Jenner
  • Myeloma Clinical Trials update — Prof Gordon Cook
  • A short term biomarker based assay predicts apoptotic response to combined BCL-2/MCL-1 BH3 mimetic targeting in myeloma cells — Dr Firas Abed
  • Loss of TRIM33 in multiple myeloma correlates with increased genomic instability — Miss Roisin McAvera
  • A ‘real-world’ study of panobinostat, bortezomib and dexamethasone in a very heavily pre-treated population of myeloma patients — Sarah Bird
  • Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving at least VGPR following PAD induction chemotherapy in the Phase II PADIMAC study — Wei Chan
• 13 Mar 2019 — Scientific Workshop 2019[ + ]

  The UKMF Scientific Workshop took place on Wednesday 13th March 2019 at the Cavendish Conference Centre in central London.

  The theme was ‘Myeloma patient Journey – Early Diagnosis to advanced disease’.

  The Michael Morley lecture was given by Prof Sigurdur Kristensson from Iceland on ‘Early diagnosis – Learnings from iSTOPP study’. We are also delighted to welcome Dr Marc Raab from the Heidelberg University Medical Centre who will present on ‘Mechanisms of resistance in multiple myeloma’.

  • Scientific Workshop Programme — Dr Martin Kaiser & Dr Karthik Ramasamy
  • Protein dynamics in early disease — Professor Mark Drayson
  • Delay in MM diagnosis — Dr Constantinos Koshiaris
  • Multiple Myeloma treatment is associated with enhanced platelet reactivity — Dr Dalia Khan
  • MRD=minimal resistant disease? — Dr Roger Owen
  • Metabolic mechanisms of resistance — Dr Holger Auner
  • Role of immune system in development in resistant MM — Professor Gordon Cook
  • Role of imaging in early diagnosis — Dr Kevin Boyd
  • iStopMM Iceland Screens, Treats or Prevents Multiple Myeloma — Prof Sigurdur Kristinsson
  • Genetics of newly diagnosed and resistant disease — Dr Martin Kaiser
• 01 Jan 1970 — Scientific Workshop 2020[ + ]

  More information to follow.

• 01 Jan 1970 — Autumn Day 2021[ + ]

  The Autumn Day will take place on Thursday 11th November 2021. Programme and venue details to follow.